Submission + - Canada's Ebola Vaccine Nets Millions for Tiny US Biotech Firm (thestar.com) 1
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada’s VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story previously discussed on /. and which continues to draw media attention.
There is something terribly wrong about this (Score:2)
Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists.
and this:
exclusive commercial licensing rights to Canada’s VSV-EBOV in 2010 with a milestone payment of just US$205,000
shame, shame, just fucking shame. taxpayer dollars being used to line the pockets of pharmacutical companies, all the meantime profiteering off a public disaster. Insult to injury is the government gets pennies on the dollar, while helping create a monopoly.(should have made vax info public domain)
Shame, shame, bloody shame on all of them.